United States· US:70771-1963_31d0470b-20e5-4d5e-b273-81d5dd6b2180
Methylene blue
A medicinal product containing methylene blue, registered in United States by Zydus Lifesciences Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- METHYLENE BLUE
- Manufacturer
- Zydus Lifesciences Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1170771196311 VIAL in 1 CARTON (70771-1963-1) / 10 mL in 1 VIAL
- ndc1170771196355 VIAL in 1 CARTON (70771-1963-5) / 10 mL in 1 VIAL
- ndc1170771-1963-1
- ndc1170771-1963-5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methylene blue in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMethylthioninium chloride (methylene blue) 100mg/10ml solution for injection ampoulesMartindale Pharmaceuticals Ltd
- BelgiumLumeblue 25 mgCosmo Technologies
- CanadaMETHYLENE BLEU LIQ 1%LABORATOIRE ATLAS INC
- CzechiaMETHYLTHIONINIUMCHLORID PROVEBLUEPROVEPHARM SAS, Marseille
- IrelandLumeblue 25 mg prolonged-release tabletsAlfasigma S.p.A
- FinlandLumeblueCosmo Technologies Limited
- SwedenMethylthioninium chloride Proveblue 5 mg/ml Injektionsvätska, lösningProvepharm SAS
- NorwayMetibloSterop
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Metiblo
- United Kingdom (Northern Ireland) · Methylthioninium Chloride Phebra Limited
- Iceland · Proveblue
- Italy · Metiltioninio Cloruro Bioindustria L.I.M., Metiltioninio Cloruro Monico
- Liechtenstein · Proveblue
- Norway · Proveblue
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef6d41b4-d42d-4497-8891-06c4491e6431 GET /v1/drugs/ef6d41b4-d42d-4497-8891-06c4491e6431?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "10",
"substance": "METHYLENE BLUE",
"productndc": "70771-1963",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA215636",
"marketing_category": "ANDA"
}See everything about methylene blue.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.